WFH NETWORK

Technology Risk Assessment of Present and Future AAV Vectors

 
Details

Year: 2018

Language: English

Author(s): Glenn Pierce

View Online
Additional Information

In the Wednesday afternoon session entitled Past, Present, and Future of Gene Therapy: From Vectors and Transgenes to Outcomes, Glenn Pierce presents current developments and perspectives in gene therapy for hemophilia A and B, focusing on the development of AAV gene transfer of FVIII and FIX.